EU Neuropathic Pain Management Market, Market Segmented by Type (Painful Diabetic Peripheral Neuropathy (PDPN), Autonomic Neuropathy, Focal Neuropathy, Proximal Neuropathy), by Indication (Diabetic Neuropathy, Spinal Stenosis, Chemotherapy Induced Peripheral Neuropathy), by Treatment (Medication and Multimodal Therapy) and by Distribution Channel (Retail Pharmacies & Drug Stores and Online Pharmacies) - Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138186
- Pages: 200
-
Format:
Report Overview
The EU Neuropathic Pain Management market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of % during the forecast period
Neuropathic pain is a complex, chronic pain state that usually is accompanied by tissue injury. It may lead to damage, dysfunction, or injury of nerve fibers, thereby leading to misfiring of signals to other pain centers. The impact of a nerve fiber injury includes a change in nerve function both at the site of injury and areas around the injury
Market Drivers
The rising prevalence of diabetic neuropathy, increasing expenditure on healthcare, and the growing incidence of trauma from injury. Other factors like rising cases of chemotherapy-induced neuropathic pain and the increasing number of patients suffering from conditions such as carpal tunnel syndrome are driving the market growth for the global neuropathic pain market
1. EU Neuropathic Pain Management Market Overview
A. Market Size
2. EU Neuropathic Pain Management Market Growth Drivers
A. Rising prevalence of diabetic neuropathy, increasing expenditure on healthcare, and the growing incidence of trauma from injury
B. Rising cases of chemotherapy-induced neuropathic pain
C. Increasing number of patients suffering from conditions such as carpal tunnel syndrome
3. EU Neuropathic Pain Management Market Segmentation
A. By Type
I. Painful Diabetic Peripheral Neuropathy (PDPN)
II. Autonomic Neuropathy
III. Focal Neuropathy
IV. Proximal Neuropathy
B. By Indication
I. Diabetic Neuropathy
II. Spinal Stenosis
III. Chemotherapy Induced Peripheral Neuropathy
C. By Treatment
I. Medication
II. Multi model Therapy
D. By Distribution Channel
I. Retail Pharmacies & Drug Stores
II. Online Pharmacies
4. EU Neuropathic Pain Management Major Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. Abbott Company overview, Product & Services, Strategies & Financials
B. Pfizer Company overview, Product & Services, Strategies & Financials
C. Glaxo Smith Kline Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Potential Growth Opportunities
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
